BAC
Bank of America Corporation
BAC has the edge over RDN overall, supported by stronger fundamentals and stronger valuation.
RDN
Radian Group Inc.
RDN trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RDN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
RDN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RDN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RDN in the historical PE scenario, which offers more potential upside but is not a forecast.
RDN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $23.35 | -36% |
| Forward | 7.1x | $36.75 | — |
| Fair | 8.1x | $33.18 | -9.7% |
| Current | 9x | $36.75 | — |
| Expensive | 9.2x | $37.34 | +1.6% |
Historical ranges are pointers, not guarantees.
RDN's PE is in its expensive range at 9.0x. If earnings grow as analysts expect, today's price would be 7.1x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over RDN on the outlook, with more favorable profitability expectations.
RDN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RDN, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over RDN on earnings, with more consistent year-over-year improvement.
RDN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.16 | +26% |
| Q3 2026 | $4.08 | +2% |
| Q2 2026 | $3.89 | -1.8% |
| Q1 2026 | $4.06 | +3.6% |
| Q4 2025 | $4.15 | +5.9% |
| Q3 2025 | $4.00 | +3.9% |
| Q2 2025 | $3.96 | +3.1% |
| Q1 2025 | $3.92 | +4% |
| Q4 2024 | $3.92 | +4% |
RDN earned $4.08 per share over the past year, up 2% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over RDN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
RDN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $624.1M | +106% |
| Q2 2026 | $575M | +81% |
| Q1 2026 | $466.3M | +47% |
| Q4 2025 | $300.5M | -4.9% |
| Q3 2025 | $303.2M | -9.2% |
| Q2 2025 | $318M | -1% |
| Q1 2025 | $318.1M | -0.4% |
| Q4 2024 | $315.9M | -3.1% |
RDN's revenue has picked up after three years of holding roughly level: $624M last quarter, up 106% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | -29 points |
| Q2 2026 | 26% | -29 points |
| Q1 2026 | 37% | -22 points |
| Q4 2025 | 67% | +7 points |
| Q3 2025 | 66% | +7 points |
| Q2 2025 | 55% | -3.5 points |
| Q1 2025 | 59% | -2.9 points |
| Q4 2024 | 60% | +4.7 points |
RDN has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RDN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $379M | +6% |
| Q2 2026 | $342.7M | +$1.1B |
| Q1 2026 | $284.3M | +327% |
| Q4 2025 | $406.1M | +$675.9M |
| Q3 2025 | $357.6M | +$595.7M |
| Q2 2025 | -$714.6M | -$506.3M |
| Q1 2025 | $66.6M | +35% |
| Q3 2024 | -$238.1M | -417% |
RDN has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RDN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RDN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -1.9M shares |
| 1 year | -2.6% | -3.5M shares |
| 3 years | -16% | -25.8M shares |
| 5 years | -29% | -53.7M shares |
| Available history | -34% | -70.8M shares |
RDN has 134M diluted shares, down 2.6% from a year ago, with $256M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $125.5M |
| Q2 2026 | $80.3M |
| Q1 2026 | $50M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $223M |
| Q1 2025 | $208.9M |
| Q4 2024 | $76M |
RDN spent $256M buying back its own shares over the past year, down 50% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RDN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q4 2019 | 0.9x | Very low |
RDN's net debt is about 1.3 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like RDN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RDN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 60.6 | Neutral |
RDN's weekly RSI is 55 (neutral) and its Stochastic is 61 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
RDN PE vs Financial Services Sector
| Metric | RDN | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 79 | 63 | 16 pts above |
RDN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RDN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.7 | 5.9% above |
| 20 week MA | $36.2 | 1.4% above |
| 50 week MA | $35.3 | 4.1% above |
| 100 week MA | $34.5 | 6.5% above |
| 200 week MA | $31.6 | 16% above |
RDN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
RDN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.3 | $20.0 | -21% |
| 2021 | $20.0 | $20.5 | +2.6% |
| 2022 | $20.5 | $19.1 | -7.1% |
| 2023 | $19.1 | $28.6 | +50% |
| 2024 | $28.6 | $31.8 | +11% |
| 2025 | $31.8 | $36.4 | +15% |
| 2026 YTD | $36.4 | $36.8 | +0.9% |
RDN has the edge over BAC on returns for 2026, with the stronger performance.